Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iLet Bionic Pancreas Bridging Study
NCT03565666Phase 3Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2018
- Primary completion
- Nov 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by Massachusetts General Hospital. Started Jul 2018; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03565666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03565666.